Oropharynx Squamous Cell Carcinoma Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Squamous Cell Carcinoma of Head and NeckOral Cavity CancerNasal Cavity Cancer+9 more
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT07063212
Recruiting
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Premalignant LesionOral Squamous Cell CarcinomaOropharynx Squamous Cell Carcinoma
Viome475 enrolled1 locationNCT05451303